Fetal Presentation of MYRF‐Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal Diagnosis
Maud Favier,Elise Brischoux‐Boucher,Louise C. Pyle,Nicolas Mottet,Marion Auber‐Lenoir,Julie Cattin,Eric Dahlen,Christelle Cabrol,Francine Arbez‐Gindre,Tania Attié‐Bitach,Odile Boute,Louise Devisme,Detlef Trost,Aicha Boughalem,David Chitayat,Lev Prasov,Odelia Chorin,Annick Rein‐Rothschild,Eran Kassif,Tal Weissbach,Laura Godfrey Hendon,Margaret P. Adam,Chloé Quelin,Sylvie Jaillard,Laura Mary,Sietse M. Aukema,Malou Heijligers,Christine de Die‐Smulders,Sander Stegmann,Lauren Badalato,Adi Ben‐Yehuda,Claire Beneteau,Pierre‐Louis Forey,Paul Kuentz,Juliette Piard
DOI: https://doi.org/10.1002/pd.6700
2024-11-21
Prenatal Diagnosis
Abstract:Purpose MYRF‐related cardiac‐urogenital syndrome (MYRF‐CUGS) is a rare condition associated with heterozygous MYRF variants. The description of MYRF‐CUGS phenotype is mostly based on postnatal cases and 36 affected individuals have been published so far. We aim now to delineate the prenatal phenotype of MYRF‐CUGS by reporting clinical data from fetuses and neonates with a pathogenic MYRF variant. Methods Detailed radiographic, pathological, clinical, and molecular data from 12 prenatal cases were collected through an international collaborative study. Adding the five fetuses previously published, we were able to study a cohort of 17 cases. Results Main ultrasound‐accessible manifestations of MYRF‐CUGS include congenital heart defects (13/17, 76%), congenital diaphragmatic hernia (10/17, 59%) and disorders of sexual differentiation in 46, XY fetuses (7/14; 50%). Postnatal examination and/or autopsy data highlighted additional birth defects and neurological findings with a large spectrum of severity. Molecular results revealed ten previously unpublished variants, one missense and nine predicted truncating variants (three frameshift, three nonsense and three splice site variants). Conclusion We report the first prenatal cohort of MYRF‐CUGS, allowing us to further characterize the variable expressivity of this rare disorder in fetuses. Severe congenital anomalies with a poor prognosis are more frequent than previously described in postnatal cases. Our data suggest that MYRF‐CUGS is characterized by a recurrent recognizable malformative association, accessible to prenatal diagnosis, with a significant intrafamilial phenotypic variability making genetic counseling challenging.
genetics & heredity,obstetrics & gynecology